Summer clinical institute in addiction studies
David Deitch, PhD, is the Founder of the Center for Criminality and Addiction Research, Training
and Application (CCARTA) at the currently Emeritus Professor of Clinical Psychiatry at the
University of California, San Diego. Dr. Deitch has over 45 years of experience in the development of drug abuse treatment systems for adolescents and adults, nationally and internationally. In the non-profit public health sector, he was Co-Founder of Daytop Village, Inc., and also served as Senior Vice President and Chief Clinical Officer for Phoenix House’s Foundation. In the academic sector, he has had appointments at Temple University, the University of Chicago, University of California at San Francisco, as well as serving as Chief of Substance Abuse Services for the University of California, San Francisco. In the government sector, he has served as Coordinator of Curriculum and Faculty for the United Nations East Central European Drug Abuse Treatment Training Project; has consulted to a variety of Department of Corrections and Ministries of Justice and Health, in Latin America, SE Asia and Europe. Dr. Deitch served during the Johnson Administration as consultant to the Presidential Commission for the Study of Crime and Juvenile Delinquency, and the National Commission on Marijuana and Drug Abuse. During the Carter Administration, he chaired the White House Task Force on Prevention. He chaired the Curriculum Development Committee of the National Addiction Technology Transfer Centers, Technical Assistance Publication Series 21 — The Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice, used today as a guideline for corrections and community based substance abuse treatment organizations. He has further served as Regional Director of the Executive Committee of the Association for Medical Education and Research in Substance Abuse — Mentor Project (2000). He has numerous publications (and videos) in the field.
Igor Koutsenok, MD, MS is а Professor of Psychiatry at the University of California San Diego, Director of the Center for Addiction Research, Training and Application, Director of the UCSD-Second Chance Reentry Academy, and a co-director of the SAMHSA South East Asia Addiction Technology Transfer Center. He graduated as a medical doctor in 1983 at the National Medical University in Kiev, (Ukraine). In 1986, he completed his psychiatry residency training and received degree as psychiatrist from the Medical University in Sofia (Bulgaria). In 1992-1996 he completed fellowship in addiction psychiatry at the University of London, Department of Addictive Behavior and Psychological Medicine at St. Georges Hospital Medical School. In 1996, he was recruited by the University of California San Diego, School of Medicine, Department of Psychiatry and since then he serves as faculty member of the Department. In 2013-2016 he served as Director of Prevention, Treatment, and Rehabilitation at the United Nations Office on Drugs and Crime, United Nations Office in Vienna. Over the last 20 years Dr. Koutsenok led the design and implementation of multiple training and technical assistance programs for addiction treatment, mental health practitioners, primary health care and social work practitioners, criminal justice professionals in the United States and around the world. Dr. Koutsenok served as a trainer for the National Drug Court Institute in the USA. Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). For many years, Dr. Koutsenok teaches general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He is a recipient of numerous national and international awards. He has authored and co-authored over 50 scientific publications and 5 book chapters. Dr. Koutsenok has been invited as a presenter and trainer to hundreds of conferences and workshops in the USA and more than 40 countries around the world. He is a proud father of three.
2018 UCSD SCI Distinguished Faculty
Robert M. Anthenelli, MD is Professor and Executive Vice Chair in the Department of Psychiatry at the University of California, San Diego, School of Medicine where he directs the Pacific Treatment and Research Center. He previously served as the Associate Chief of Staff for Mental Health at the VA San Diego Healthcare System and Vice Chair for Veterans Affairs. He was formerly a Professor of Psychiatry, Psychology and Neuroscience at the University of Cincinnati, College of Medicine where he founded and directed the
Center for Treatment, Research & Education in Addictive Disorders and the Addiction Sciences Division.
Dr. Anthenelli earned his baccalaureate degree from The Johns Hopkins University in Baltimore, Maryland, USA and his MD degree from The Johns Hopkins University School of Medicine. After graduating medical school, he completed his internship in internal medicine at Mercy Hospital in Baltimore. Dr. Anthenelli did residency training in psychiatry at the University of California, San Diego, School of Medicine. Additional post-doctoral training included a 2-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.
The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco and alcohol dependence by better understanding the neurobiology of these disorders. His lab group is also interested in the genetic influences on these disorders, the relationship between stress and relapse to addiction, and sex differences in stress and treatment responsivity. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the Department of Veterans Affairs, and various industry sponsors.
Kara S. Bagot, MD is a Child and Adolescent Psychiatrist and Assistant Professor in the University of California, San Diego Department of Psychiatry. She received her psychiatric and clinical research training at Yale University Child Study Center. Dr. Bagot is a clinician and researcher with expertise in treatment interventions for adolescent Substance Use Disorders, and has authored and presented several manuscripts in this field. Her research focuses on understanding psychosocial, biological and psychiatric factors that contribute to the developmental trajectory of substance use in adolescents, and development of efficacious treatment interventions that can be implemented in naturalistic settings.
Jim Carter, PhD currently works as a senior consultant at Learning Designs, Inc. He enjoys providing consultation and staff training focused on Motivational Interviewing (MI) and Cognitive Behavioral Therapies (CBT). Dr. Carter is a member of Motivational Interviewing Network of Trainers (MINT), and a diplomate for the Academy of Cognitive Therapy. Since 1999, he has held a license as a clinical psychologist, and has treated patients in hospital, correctional, and private practice settings. Dr. Carter possesses specialized training in the areas of addiction, behavioral pharmacology, MI, CBT, and staff training and development. He served as Associate Director of Addiction Treatment Services at Johns Hopkins Bayview Medical Center, and as Instructor in the Department of Psychiatry at Johns Hopkins School of Medicine. During the course of his career, Dr. Carter has authored research articles in scientific journals, served as an expert reviewer, and as a co-principal investigator of publicly funded clinical trial research studies. He is a husband, father, and avid saltwater angler.
Thom Browne, Jr., MA Rubicon Global Enterprises: President and CEO (Aug. 2015 – present) Colombo Plan Secretariat: Chief Executive Officer (Jan. 2016 – present) Provides global technical assistance on drug prevention, treatment, recovery, and criminal justice issues. Chairs international working groups to develop certification for addictions counselors, licensing for treatment centers, and networks of treatment/prevention professionals. Serves as expert advisor to selected international organizations on counter- narcotics issues. Develops specialized programs addressing unique international challenges such as identification of toxic adulterants added to drugs of abuse and related public health responses. Developed the U.S. government's program and approach to international drug demand reduction for over 25 years as the U.S. Department of State's Division Director for Criminal Justice Programs.
David Grelotti, MD is an Assistant Professor of Psychiatry at the University of California San Diego and an Investigator at the University of California Center for Medicinal Cannabis Research. He graduated from medical school at The Johns Hopkins University School of Medicine and completed residency training in the Harvard Medical School Combined Pediatrics, Adult Psychiatry, and Child Psychiatry Residency Training Program at Massachusetts General Hospital and McLean Hospital. After residency training, he worked extensively in Haiti and Africa to close the treatment gap for mental, neurological, and substance use disorders. At UC San Diego, he is the Director of HIV Psychiatry and conducts research on HIV syndemics, global mental health, and medicinal cannabis. Active research efforts include: novel systems for the delivery of mental health treatment for people living with HIV in Haiti and the US; the relationship between HIV and cannabis, heroin, and recreational antiretroviral use in South Africa; and cannabis-related driving impairment and a randomized, placebo-controlled clinical trial of cannabis for low back pain at the Center for Medicinal Cannabis Research. His research is funded by the National Institutes of Health and the State of California.
Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of California San Diego. Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid psychiatric conditions. She previously worked at a large outpatient addiction treatment program serving over 5000 patients. Her academic interests focus on implementation research and large-data health outcomes for patients with substance use disorders, as well as training and education in Motivational Interviewing. She attended Baylor College of Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction. During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships. She completed a fellowship in Addiction Psychiatry at Yale. During residency and her early faculty years, she founded and led the Yale Global Mental Health Program. She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry. She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program. This will be a full service ambulatory program for the treatment of substance use and other co-occurring mental disorders (i.e. anxiety, depression, PTSD), offering a continuum of services including a comprehensive evaluation, individual, family and group therapy, medication management, and linkage to community resources. She is the Director for Addiction Services and the Medical Director of the Addiction Recovery and Treatment Program at UCSD.
Marc A. Schuckit, MD, is Professor of Psychiatry and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA San Diego Healthcare System. Dr. Schuckit received his BS from the University of Wisconsin, an MD from Washington University, interned at Cedars Sinai Medical Center, and was a resident in psychiatry at Washington University and UCSD. He was a special advisor to the Commanding Officer of the Naval Health Research Center, and the first Director of the Alcohol and Drug Institute, University of Washington (1975-1978). He returned to San Diego as Professor and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA San Diego Healthcare System. Dr. Schuckit’s major focus is alcohol and drugs. He was Chair of the DSM-IV substance disorders workgroup and has published papers about the optimal diagnostic criteria for substance use disorders. Regarding the genetics of alcoholism, he has carried out adoption studies, identified a genetic characteristic that impacts on elevated alcoholism risk (the low level of response to alcohol), and is now searching for related genes. He is currently completing a 20-year follow-up (97% success rate) of sons of alcoholics where he is trying to identify environmental events that might relate to whether biological predisposition toward alcohol dependence is expressed. An additional research area is co-morbidity between substance use disorders and major psychiatric conditions.
Dr. Schuckit directs the Alcohol and Drug Treatment Program at the VA San Diego Healthcare System, supervising residents, medical students and staff. He is also a major contact person regarding alcohol and drug problems in faculty and staff at UCSD and the San Diego VA. Additional clinical interests include the treatment of depressive disorders, anxiety conditions, and geriatric psychiatric populations.
Joseph Skrajewski, MA, MFTI, is executive director of Medical and Professional Education at the Hazelden Betty Ford Foundation. He leads the Summer Institute for Medical Students (SIMS), Professionals in Residence (PIR) program, Addiction Medicine Fellowship, and Course on Addiction and Recovery Education (CARE), while also overseeing program design, development and medical education partnerships. Joseph serves on the board of the Desert Chapter of the California Association of Marriage and Family Therapists and as an Adjunct Clinical Instructor of Family Medicine at the University of Southern California's Keck School of Medicine. He has presented all over the world on numerous topics related to addiction, and is a person in long-term recovery himself. Before entering the fields of psychology and healthcare, Joseph worked on Wall Street.
María Luisa Zúñiga, PhD is Professor in the School of Social Work at San Diego State University (SDSU) and Associate Adjunct Professor in the Division of Global Public Health and Department of Pediatrics, UC San Diego (UCSD). Serves as the Campus Director of the SDSU-UCSD Joint Doctoral Program in Interdisciplinary Research on Substance Use (JDP) (http://socialwork.sdsu.edu/irsu/). The JDP is a new doctoral program designed to train the next generation of substance use researchers to lead high caliber, high impact and meaningful substance use research to reduce the impact of problems related to substance use, misuse, addiction and co-occurring conditions.
She is an epidemiologist with over 18 years of experience conducting transnational and Community-Based Participatory Research. Dr. Zúñiga’s research goal is to improve health among persons of Latin American origin who are at risk for or adversely impacted by alcohol and drug use, poor mental health, and TB/HIV. She has worked extensively with immigrant communities and communities in the U.S.-Mexico border region as well as Mexican transnational and domestic migrants and their families in Mexico. Her ongoing research is designed to understand and improve engagement and retention of patients in health care, patient-clinician communication, and binational care continuity in the context of the U.S.-Mexico border region. Specific populations with whom she works include persons living with HIV and/or Tuberculosis, and persons impacted by substance abuse. Recent efforts include development of interdisciplinary collaborations in HIV/TB/Substance use research with colleagues in the U.S. and Brazil.